期刊文献+

低钠透析对合并顽固性高血压尿毒症患者血压和心脏功能的影响 被引量:7

Effects of low sodium dialysis on blood pressure and heart function in uremic patients with refractory hypertension
下载PDF
导出
摘要 目的探讨相对性低钠透析对合并顽固性高血压的尿毒症患者血压和心脏功能的影响及其安全性。方法将合并顽固性高血压的维持性血液透析患者80例随机分为2组,A组透析液钠离子浓度为135 mmol/L,B组透析液钠离子浓度为140 mmol/L。观察透析6周后2组患者血压、体质量、血清尿素氮(BUN)、肌酐(SCr)、K t/v值、左房内径(LAD)、左室舒张末内径(LVDd)、左室收缩末内径(LVD s)、左室射血分数(LVEF)的变化,比较2组患者透析期间不良反应的发生率。结果 A组患者在治疗后收缩压、舒张压、LAD、LVDd、LVD s和体质量较治疗前均显著降低,LVEF较治疗前显著增加,但血清尿素氮、肌酐和K t/v无显著变化。B组患者治疗后上述各项指标与治疗前比较均无显著性差异。A组患者透析时高血压的发生率显著低于B组,透析时低血压、低血糖、心律失常、透析失衡和心力衰竭发生率2组间比较无显著性差异。结论相对性低钠透析可有效降低血压和改善患者心脏功能,合并顽固性高血压的尿毒症患者短期使用安全有效。 Objective It is to discuss the effects and safety of relatively low sodium dialysis in uremic patients with refractory hypertension.Methods Eighty uremic patients with refractory hypertension were randomly divided into 2 groups.In group A sodium concentration of dialysate was 135 mmol/L,and that of group B was 140 mmol/L.The changes of blood pressure,bodymass,serum BUN and SCr,Kt/v,LAD,LVDd,LVDs and LVEF were observed in both groups after 6 weeks' dialysis,and the occuring rates of side effect during dialysis stage between the two groups were compared.Results After 6 weeks' treatment in group A,the blood pressure,bodymass,LAD,LVDd and LVDs were decreased markedly after treatment,and their LVEF was improved significantly,but no significant change of serum BUN,SCr and Kt/v were found.Compared with that before treatment,there was no significant difference in the indexes above after treatment in group B.Incidence rate of hypertension during dialysis in group A was significantly lower than that in group B,and no statistical difference was found in other adverse reactions such as hypotension,hypoglycemia,arrhythmia,dialysis disbalance and heart failure between two groups.Conclusion Relatively low sodium dialysate hemodialysis can effectively low down blood pressure and improve patient's heart function,it is safe and effective to treating for uremic patients with refractory hypertension.
机构地区 解放军第
出处 《现代中西医结合杂志》 CAS 2011年第25期3126-3128,共3页 Modern Journal of Integrated Traditional Chinese and Western Medicine
关键词 血液净化 尿毒症 顽固性高血压 低钠透析 心脏功能 blood purification uremia refractory hypertension low sodium dialysate cardiac function
  • 相关文献

参考文献11

  • 1Takeda A,Toda T,Fujii T,et al.Discordance of influence of hypertension on mortality and cardiovascucar risk in hemodialysis patient[J].Am J Kidney Dis,2005,45(1):112-118.
  • 2杨秀芹,孙玉兰.血液透析加血液灌流治疗尿毒症顽固性高血压[J].中国血液净化,2004,3(8):462-462. 被引量:77
  • 3Zager PG,Nikolic J,Brown RH,et al.Ucurve association of blood pressure and mortality in hemodialysis patient[J].Medical Directors of Dialysis Clinic Inc Kidney Int,1998,54(2):561-569.
  • 4Silberberg JS,Barre PE,Prichard SS,et al.Impact of left ventricular hypertrophy on survial in end stage renal disease[J].Kidney Int,1989,36:286-290.
  • 5Locatelli F,Covic A,Chazot C,et al.Hypertension and cardiovascular risk assessment in dialysis patients[J].Nephrol Dial Transplant,2004,19:1058-1068.
  • 6Agarwal R,Nissenson AR,Batlle D,et al.Prevalence,treatment,and control of hypertension in chronic hemodialysis patients in the united states[J].Am J Med,2003,115:291.
  • 7Grekas D,Bamichas G,Bacharaki D.Hypertension in chronic hemodialysis patients:current view on pathophysiology and treatment[J].Clin Nephrol,2000,53:164.
  • 8Rahman M,Smith MC.Hypertension in hemodialysis patients[J].Curr Hypertens Rep,2001,3(6):496.
  • 9付荣国,王莉,郭蕊军,张红利,赵莉,郭芳丽.在线血液透析滤过对终末期肾衰竭高血压患者的治疗作用[J].临床内科杂志,2006,23(5):322-324. 被引量:24
  • 10Ansari A,Kaupk CJ,Vaziri ND,et al.Cardiac pathology in patients with end stage renal disease maintained on hemodialysis[J].Int J Atvi Organs,1993,16:31-36.

二级参考文献20

  • 1Davies SJ, Woodrow G, Donovan K, et al. Icodexitrin improves the fluid status of peritoneal dialysis patients: Results of a double- blind randomized controlled trial. J Am Soc Nephrol, 2003, 14:2338-2344
  • 2Nakayama M, Kawatuchi Y. Multicenter survey on hydration status and control of blood pressure in Japanses CAPD patients. Perit Dial Int,2002, 22:411-418
  • 3Rippe B. A three- pore model of peritoneal transport. Perit Dial Int,1992, 13 (1): S35-S38
  • 4Rippe B, Stelin G. Simulations of peritoneal solute transport during CAPD, application of two - pore formalism. Kidney International,1989, 35: 1234-1244
  • 5Rippe B, Stelin G, and Haraldsson B. Computer simulations of peritoneal fluid transport in CAPD. Kidney International, 1991, 40: 315-325
  • 6Amici G. Mathmatical models for prescription and delivery in peritoneal dialysis. Nephrol Dial Transplant, 1998, 13: 120-124
  • 7Locatelli F, Covic A, Chazot C et al. Hypertension and cardiovascular risk assessment in dialysis patients. Nephrol Dial Transplant, 2004, 19:1058- 1068
  • 8Churchill DN, Taylor DW, Keshaviah PR et al. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J AmSoc Nephrol, 1996, 7:198-207
  • 9Szeto CC, Wong TY, Chow KM, et al. Impact of dialysis adequacy in mortality and morbidity of anuric Chinese patients receiving continuous ambulatory peritoneal dialysis. J Am Soc Nephrol, 2001, 12:43- 45
  • 10Paniagua R, Amato D, Vonesh E, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol, 2002,13: 1307- 1320

共引文献99

同被引文献73

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部